MenaQ7 MK-7
MenaQ7 MK-7 es un suplemento de vitamina K2, específicamente la variante MK-7, que juega un papel crucial en la coagulación de la sangre y la salud ósea. Es una forma de menaquinona, un tipo de vitamina K.
Resumen de Efectividad y Riesgos
Condición | Efectividad | Detalles |
|---|---|---|
| Osteoporosis | MenaQ7 MK-7's role in bone health is well-documented. It helps in the carboxylation of osteocalcin, which is essential for bone mineralization. This action is associated with improved bone density and reduced risk of osteoporotic fractures. | |
| Salud Cardiovascular | By reducing arterial calcification and improving blood vessel elasticity, MenaQ7 MK-7 contributes to overall cardiovascular health. Its effects on MGP activation are crucial for preventing the calcification of arteries, thereby reducing cardiovascular risk. | |
| Salud Ósea | MenaQ7 MK-7 is involved in the activation of osteocalcin, a protein necessary for bone mineralization. Studies have demonstrated its role in improving bone mineral density and reducing the risk of fractures, particularly in postmenopausal women. | |
| Calcificación Vascular | MenaQ7 MK-7 has been shown to reduce vascular calcification by activating MGP. This is critical for maintaining vascular health and preventing cardiovascular diseases associated with calcification. | |
| Calcificación arterial/aterosclerosis | MenaQ7 MK-7 has been shown to inhibit arterial calcification and reduce the risk of cardiovascular disease by activating matrix Gla protein (MGP), a potent inhibitor of arterial calcification. Clinical trials and meta-analyses support its efficacy in reducing arterial stiffness and calcification. | |
| Potencial interacción con anticoagulantes. | MenaQ7 MK-7 puede interactuar con medicamentos anticoagulantes como la warfarina, lo que potencialmente altera su eficacia o aumenta el riesgo de sangrado. |
Suplemento Recomendado